HOLX

NEUTRALM&A

Hologic, Inc.

2026-04-01

Price

$75.60

+0.01%

Score5.8Watchlist

Signals4/8 DNA2/13 Act · 0/4 Risk

SentimentNEUTRALScore: 5

Volume0.7xvs 20d avg

Analysis

Hologic (HOLX) is trading as a pure merger arbitrage play due to its pending $18.3 billion take-private acquisition by Blackstone and TPG. The stock is pinned at $75.60, just beneath the $76.00 base cash consideration, which perfectly explains the artificially strong technical signals (ALPHA_MALE, PERFECT_STACK) and ultra-low 2.5% annualized volatility. In the context of the current CAUTION macro regime, this idiosyncratic M&A catalyst provides a high-conviction, uncorrelated safe haven, explaining its +4.5% relative strength versus the SPY. Investors are currently capturing a tight 40-cent spread while acquiring free optionality on a $3.00 Contingent Value Right (CVR) tied to future revenue targets.

Fired Signals

ALPHA MALESTEADY CLIMBGOLDEN CROSSPERFECT STACKMOMENTUM SHIFTINSIDE OUT

Key Takeaways

Actionable Thesis: HOLX is a high-conviction merger arbitrage play offering a ~0.5% cash spread to the $76.00 deal price [2.1], plus free optionality on a $3.00 CVR.
Key Risk: Deal collapse due to unforeseen regulatory or financing hurdles, which would cause a severe re-pricing to pre-deal levels.
What to Watch: Final regulatory clearances and the official closing date expected in the first half of 2026.

← Back to 2026-04-01 View Full HOLX History →Yahoo Finance &nearr;